What question did this study set out to answer?

The review aims to provide an overview of ongoing trials for HIV PrEP focused on cisgender women, examining both biomedical and behavioral interventions.

June 8, 2026Current Infectious Disease ReportsOpen Access

Advancing HIV Pre-Exposure Prophylaxis (PrEP) for Women: A Review of Ongoing Trials on Drug Development and Behavioral Interventions

View Full Paper

Ask AI

Bookmark

Authors

SGSwarnali GoswamiUniversity of Mississippi PMP MasurkarUCB Pharma (United States)CSChintal H. ShahRutgers, The State University of New Jersey

Discussion

Member takes

Implication

Narrative review highlights ongoing clinical trials for HIV PrEP drug development and behavioral strategies in women, indicating significant improvements.

Key Points

The review aims to provide an overview of ongoing trials for HIV PrEP focused on cisgender women, examining both biomedical and behavioral interventions.
Narrative review of ongoing clinical trials using ClinicalTrials.gov as the data source.
Analysis includes 6 biomedical and 22 behavioral intervention trials focused on HIV PrEP among cisgender women.
Trials involve diverse geographical settings and assess various PrEP regimens and adherence outcomes.
Identified 6 biomedical intervention trials evaluating drugs like TDF/FTC and long-acting agents, involving 30 to 9,000 participants.
22 behavioral intervention trials focusing on mobile apps, social media, and counseling, with adherence as a primary outcome.
Emphasis on equity highlighted, targeting underserved adolescent girls and young women globally.

Cite This Study

Goswami et al. (2026) studied this question.

synapsesocial.com/papers/6a265ca8ad53cfb9357c5dbd https://doi.org/10.1007/s11908-026-00883-5

View Full Paper

Ask AI

Bookmark

Implication

Narrative review highlights ongoing clinical trials for HIV PrEP drug development and behavioral strategies in women, indicating significant improvements.

Advancing HIV Pre-Exposure Prophylaxis (PrEP) for Women: A Review of Ongoing Trials on Drug Development and Behavioral Interventions

Discussion

Member takes

Implication

Key Points

Cite This Study

Advancing HIV Pre-Exposure Prophylaxis (PrEP) for Women: A Review of Ongoing Trials on Drug Development and Behavioral Interventions

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider